Detalhe da pesquisa
1.
The initial molecular response predicts the deep molecular response but not treatment-free remission maintenance in a real-world chronic myeloid leukemia cohort.
Haematologica
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38695126
2.
Value of combining biological age with assessment of individual frailty to optimize management of cancer treated with targeted therapies: model of chronic myeloid leukemia treated with tyrosine kinase inhibitors (BIO-TIMER trial).
BMC Cancer
; 24(1): 661, 2024 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38816821
3.
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
Br J Haematol
; 200(2): 175-186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214090
4.
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory.
Ann Hematol
; 101(10): 2241-2255, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36040480
5.
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma.
Blood
; 129(18): 2471-2478, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28270452
6.
Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.
Haematologica
; 104(6): 1150-1155, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573507
7.
Bone marrow hematons: An access point to the human hematopoietic niche.
Am J Hematol
; 92(10): 1020-1031, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28639326
8.
Impact of ATG Dose on the Outcome of Patients Undergoing Reduced Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
Acta Haematol
; 136(4): 193-200, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27623172
9.
Outcome and impact of post-remission strategy after MIDAM regimen in patients with relapsing or refractory acute myeloid leukemia.
Am J Hematol
; 94(1): E32-E35, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370957
10.
Measurement of imatinib uptake by flow cytometry.
Cytometry A
; 81(11): 996-1004, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22930640
11.
COVID-19 systematic screening of asymptomatic haematopoietic stem cell donors: Less if often more.
EJHaem
; 2022 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36248619
12.
Efficiency of nilotinib to target chronic phase-chronic myeloid leukaemia primary mature CD34- and immature CD34+ cells.
Sci Rep
; 11(1): 6187, 2021 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33731863
13.
[Second allogeneic hematopoietic stem cell transplant: Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]. / Seconde allogreffe : recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Bull Cancer
; 106(1S): S40-S51, 2019 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-30409466
14.
Prevalence of malnutrition in adult patients previously treated with allogeneic hematopoietic stem-cell transplantation.
Clin Nutr
; 37(2): 739-745, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28390845
15.
DNA methylation profiling reveals a pathological signature that contributes to transcriptional defects of CD34+ CD15- cells in early chronic-phase chronic myeloid leukemia.
Mol Oncol
; 12(6): 814-829, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29575763
16.
Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study.
Exp Hematol
; 67: 41-48, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30195076
17.
[How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)]. / Conduite à tenir devant une réactivation EBV et un syndrome lymphoprolifératif à EBV, une réactivation ou infection à CMV et à HHV-6 après allogreffe de cellules souches hématopoïétiques : recommandations de la SFGM-TC (mises à jour).
Bull Cancer
; 104(12S): S181-S187, 2017 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-29169653
18.
[Assessment and management of post-transplant iron overload: Guidelines of the Francophone Society of Marrow Transplantation and Cellular Therapy (SFGM-TC)]. / Évaluation et prise en charge de la surcharge en fer post-greffe : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).
Bull Cancer
; 103(11S): S255-S266, 2016 Nov.
Artigo
em Francês
| MEDLINE | ID: mdl-27842863
19.
[Management of the cardiovascular disease risk during nilotinib treatment in chronic myeloid leukemia: 2015 recommendations from the France Intergroupe des Leucémies Myéloïdes Chroniques]. / Recommandations 2015 du France Intergroupe des Leucémies Myéloïdes Chroniques pour la gestion du risque d'événements cardiovasculaires sous nilotinib au cours de la leucémie myéloïde chronique.
Bull Cancer
; 103(2): 180-9, 2016 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-26790711
20.
Could enteral nutrition improve the outcome of patients with haematological malignancies undergoing allogeneic haematopoietic stem cell transplantation? A study protocol for a randomized controlled trial (the NEPHA study).
Trials
; 16: 136, 2015 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25872934